Treating male partners in addition to women with bacterial vaginosis results in a lower rate of recurrence than treating only ...

Results Two hundred and fifteen subjects were randomised. Metronidazole and clarithromycin containing regimens achieved high cure rates: 94 of 97 (96.9%, 95% CI 93.5% to 100%) and 93 of 98 (94.9%, 95% ...

Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of ...

q.d. Solution: 10 mg/ml (25 vials, 2 ml) US$125 † Metronidazole 500 mg p.o. q 12 h for 14 days Tablets: 500 mg (28 tablets) US$12.12 † Probenecid 1 g p.o. administered concurrently with ...

as a single dose) and doxycycline (100 mg, one capsule b.i.d.), and placebo (two capsules t.i.d. for equivalent diseases of clindaymycin) for 14days 61/64 Comparators were either metronidazole ...

This study marks an important step forward in recognizing the role of both partners in BV recurrence and could change how ...

Treating the male sexual partners of women with bacterial vaginosis significantly reduced recurrence, according to an ...

The addition of treatment for male partners reduced the recurrence of bacterial vaginosis among women enrolled in a randomized trial compared with treating only the women, researchers reported.

It found that an intravenous bolus of 500 mg of acetazolamide in combination with intravenous loop diuretic therapy significantly increased the rate of successful decongestion and reduced hospital ...